Bora Pharmaceuticals

Update in progress

6472.TW (Taiwan)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Bora Pharmaceuticals Co., LTD. focuses on contract development, manufacturing, and sale of pharmaceuticals in Europe, the United States, Taiwan, and globally. It operates through Sales, CDMO, and Other segments, producing generic, brand, and over‑the‑counter drugs. It also provides CDMO and technical development services for pharma products, and offers Western medicines such as CNS drugs, antibiotics, GI products, plus nutritional and health care items. It sells directly to clinics, pharmacies, chains, and drug stores, and via distributors to medical centers and hospitals. Established in 2007, it is based in Taipei, Taiwan.

Company score

Sentiment: 0.32; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.31; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.11; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive